Email this article Pregnancy outcomes in women with hyperhomocysteinemia and benign uterine tumors
- Authors: Hamidullina E.F.1, Davidyan L.Y.1
-
Affiliations:
- Ulyanovsk State University
- Issue: Vol 19, No 5-6 (2019)
- Pages: 30-38
- Section: Clinical Medicine
- URL: https://journals.rcsi.science/2410-3764/article/view/33866
- ID: 33866
Cite item
Abstract
In pregnant women with benign tumors of the uterus, development of endothelial dysfunction and its clinical manifestation including placental insufficiency, miscarriage, gestosis, malformation of the nervous tube in the fetus in early pregnancy, is often associated with hyperhomocysteinemia. The treatment of hyperhomocysteinemia before gestation allows to reduce the incidence of pregnancy complications in these women by 1.5 times. The purpose of the work is to evaluate pregnancy outcomes in women who have undergone the treatment of hyperhomocysteinemia combined with benign tumor of the uterus. Conclusion. Having analyzed the outcomes of pregnancies and the state of the newborns of women diagnosed with benign tumor of the uterus, we can conclude that prevention of gestational complications by improving hormonal and biochemical parameters, despite the presence of hyperhomocysteinemia, the number of complications, including the development of fetoplacental failure associated with clinically manifested chronic hypoxia of the fetus, is reduced by 1.5 times.
Full Text
##article.viewOnOriginalSite##About the authors
Elmira F. Hamidullina
Ulyanovsk State University
Author for correspondence.
Email: khamidullina2012@mail.ru
Postgraduate student, Department of Postgraduate Education and Family Medicine
Russian Federation, UlyanovskLiana Yu. Davidyan
Ulyanovsk State University
Email: a.bogdasarov@mail.ru
Doctor of Medical Sciences, Professor, Department of Postgraduate Education and Family Medicine
Russian Federation, UlyanovskReferences
- Болдина Е.Б., Озолиня Л.А., Патрушев Л.И., Патрушева Н.Л. Генетически обусловленные дефекты гемостаза, предрасполагающие к тромбозам, их значимость в акушерстве и гинекологии / Материалы V Международной конференции молодых ученых «Современные вопросы акушерства, гинекологии и перинатологии»; Москва, 20 мая 2011 г. // Вестник Российского государственного медицинского университета. Специальный выпуск. – 2011. – № 2. – С. 4–9. [Boldina EB, Ozolinya LA, Patrushev LI, Patrusheva NL. Geneticheski obuslovlennyye defekty gemostaza, predraspolagayushchiye k trombozam, ikh znachimost’ v akusherstve i ginekologii. (Conference proceedings) Mezhdunarodnaya konferentsiya molodykh uchenykh “Sovremennyye voprosy akusherstva, ginekologii i perinatologii”; Moscow, 2011 May 20. Vestnik RGMU. Special issue. 2011;(2):4-9. (In Russ.)]
- Бутенко А.В. Гомоцистеин: влияние на биохимические процессы в организме человека // Молодой ученый. – 2016. – № 1. – С. 78–82. [Butenko AV. Gomotsistein: vliyaniye na biokhimicheskiye protsessy v organizme cheloveka. Molodoy uchenyy. 2016;(1):78-82. (In Russ.)]
- Озолиня Л.А. Распространенность мутаций в генах фактора V (G1691A, Leiden), протромбина (G20210A) и метилентетрагидрофолатредуктазы (C677T) среди беременных московской популяции и их связь с патогенезом // Тромбоз, гемостаз и реология. – 2001.– № 1. – С. 47–53. [Ozolinya LA. Rasprostranennost’ mutatsiy v genakh faktora V (G1691A, Leiden), protrombina (G20210A) i metilentetragidrofolatreduktazy (C677T) sredi beremennykh moskovskoy populyatsii i ikh svyaz’ s patogenezom. Tromboz, gemostaz i reologia. 2001;(2):47-53. (In Russ.)]
- Озолиня Л.А., Лапина И.А., Игнатченко О.Ю., и др. Гипергомоцистеинемия и репродуктивная функция // Вестник Российского государственного медицинского университета. – 2010. – № 4. – С. 46–49. [Ozolinya LA, Lapina IA, Ignatchenko OYu, et al. Gipergomotsisteinemiya i reproduktivnaya funktsiya. Vestnik RGMU. 2010;(4):46-49. (In Russ.)]
- Озолиня Л.А., Кашежева А.З. Прегравидарная подготовка женщин с гипергомоцистеинемией // Гинекология. – 2013. – Т. 15. – № 2. – С. 67–70. [Ozolinya LA, Kashezheva AZ. Pregravidal preparation for women with hyperhomocysteinemia. Gynecology. 2013;15(2):67-70. (In Russ.)]
- Тютюнник В.Л., Кан Н.Е., Мантрова Д.А., и др. Роль полиморфизма гена метилентетрагидрофолатредуктазы (MTHFR) в формировании задержки роста плода // Акушерство и гинекология. – 2018.– № 12. – С. 23–28. [Tyutyunnik VL, Kan NE, Mantrova DA, et al. The role of methylentetrahydrofolate reductase (MTHFR) gene polymorphism in intrauterine growth restriction development. Akush Ginekol (Mosk). 2018;(12):23-28. (In Russ.)]. https://doi.org/10.18565/aig.2018.12.23-28.
- Biesalski HK, Tinz J. Multivitamin/mineral supplements: rationale and safety – a systematic review. Nutrition. 2017;33:76-82. https://doi.org/10.1016/j.nut.2016. 02.013.
- Hodgetts VA, Morris RK, Francis A, et al. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG. 2015;122(4):478-490. https://doi.org/10.1111/1471-0528.13202.
Supplementary files
